These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase alpha. Kacher Y, Golan A, Pewzner-Jung Y, Futerman AH. Blood Cells Mol Dis; 2007 Feb 01; 39(1):124-9. PubMed ID: 17482853 [Abstract] [Full Text] [Related]
25. Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease. van Weely S, Brandsma M, Strijland A, Tager JM, Aerts JM. Biochim Biophys Acta; 1993 Mar 24; 1181(1):55-62. PubMed ID: 8457606 [Abstract] [Full Text] [Related]
26. Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice. Xu YH, Xu K, Sun Y, Liou B, Quinn B, Li RH, Xue L, Zhang W, Setchell KD, Witte D, Grabowski GA. Hum Mol Genet; 2014 Aug 01; 23(15):3943-57. PubMed ID: 24599400 [Abstract] [Full Text] [Related]
28. X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease. Premkumar L, Sawkar AR, Boldin-Adamsky S, Toker L, Silman I, Kelly JW, Futerman AH, Sussman JL. J Biol Chem; 2005 Jun 24; 280(25):23815-9. PubMed ID: 15817452 [Abstract] [Full Text] [Related]
29. Study of beta-glucosidase from Helix pomatia by active site-directed inhibitors. Donsimoni R, Legler G, Bourbouze R, Lalegerie P. Enzyme; 1988 Jun 24; 39(2):78-89. PubMed ID: 2969330 [Abstract] [Full Text] [Related]
32. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease. Mucci JM, Suqueli García F, de Francesco PN, Ceci R, Di Genaro S, Fossati CA, Delpino MV, Rozenfeld PA. Gene; 2013 Dec 15; 532(2):186-91. PubMed ID: 24076352 [Abstract] [Full Text] [Related]
33. Conduritol aziridine: a new mechanism-based glucosidase inactivator. Caron G, Withers SG. Biochem Biophys Res Commun; 1989 Aug 30; 163(1):495-9. PubMed ID: 2673241 [Abstract] [Full Text] [Related]
34. The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects. Stephens MC, Bernatsky A, Burachinsky V, Legler G, Kanfer JN. J Neurochem; 1978 May 30; 30(5):1023-7. PubMed ID: 96213 [No Abstract] [Full Text] [Related]
35. Inhibitors of beta-glucosidases of animal tissues. Radin NS. Adv Exp Med Biol; 1978 May 30; 101():589-600. PubMed ID: 96666 [No Abstract] [Full Text] [Related]
36. Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease. Hamler R, Brignol N, Clark SW, Morrison S, Dungan LB, Chang HH, Khanna R, Frascella M, Valenzano KJ, Benjamin ER, Boyd RE. Anal Chem; 2017 Aug 15; 89(16):8288-8295. PubMed ID: 28686011 [Abstract] [Full Text] [Related]
37. β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology. Ridley CM, Thur KE, Shanahan J, Thillaiappan NB, Shen A, Uhl K, Walden CM, Rahim AA, Waddington SN, Platt FM, van der Spoel AC. J Biol Chem; 2013 Sep 06; 288(36):26052-26066. PubMed ID: 23880767 [Abstract] [Full Text] [Related]
38. New aminocyclitols as modulators of glucosylceramide metabolism. Egido-Gabás M, Serrano P, Casas J, Llebaria A, Delgado A. Org Biomol Chem; 2005 Apr 07; 3(7):1195-201. PubMed ID: 15785807 [Abstract] [Full Text] [Related]
39. Human acid beta-glucosidase: inhibition studies using glucose analogues and pH variation to characterize the normal and Gaucher disease glycon binding sites. Osiecki-Newman K, Legler G, Grace M, Dinur T, Gatt S, Desnick RJ, Grabowski GA. Enzyme; 1988 Apr 07; 40(4):173-88. PubMed ID: 3234317 [Abstract] [Full Text] [Related]